These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
560 related articles for article (PubMed ID: 29413518)
1. Unique Effects of Clozapine: A Pharmacological Perspective. Khokhar JY; Henricks AM; Sullivan EDK; Green AI Adv Pharmacol; 2018; 82():137-162. PubMed ID: 29413518 [TBL] [Abstract][Full Text] [Related]
2. Clozapine for comorbid substance use disorder and schizophrenia: do patients with schizophrenia have a reward-deficiency syndrome that can be ameliorated by clozapine? Green AI; Zimmet SV; Strous RD; Schildkraut JJ Harv Rev Psychiatry; 1999; 6(6):287-96. PubMed ID: 10370435 [TBL] [Abstract][Full Text] [Related]
4. A systematic review of the evidence of clozapine's anti-aggressive effects. Frogley C; Taylor D; Dickens G; Picchioni M Int J Neuropsychopharmacol; 2012 Oct; 15(9):1351-71. PubMed ID: 22339930 [TBL] [Abstract][Full Text] [Related]
5. Clozapine reconstructed: Haloperidol's ability to reduce alcohol intake in the Syrian golden hamster can be enhanced through noradrenergic modulation by desipramine and idazoxan. Khokhar JY; Chau DT; Dawson R; Green AI Drug Alcohol Depend; 2015 Jul; 152():277-81. PubMed ID: 25979645 [TBL] [Abstract][Full Text] [Related]
6. The expanding indications for clozapine. Young CR; Longhurst JG; Bowers MB; Mazure CM Exp Clin Psychopharmacol; 1997 Aug; 5(3):216-34. PubMed ID: 9260069 [TBL] [Abstract][Full Text] [Related]
7. Clozapine's critical role in treatment resistant schizophrenia: ensuring both safety and use. Remington G; Lee J; Agid O; Takeuchi H; Foussias G; Hahn M; Fervaha G; Burton L; Powell V Expert Opin Drug Saf; 2016 Sep; 15(9):1193-203. PubMed ID: 27207070 [TBL] [Abstract][Full Text] [Related]
9. Equivalent occupancy of dopamine D1 and D2 receptors with clozapine: differentiation from other atypical antipsychotics. Tauscher J; Hussain T; Agid O; Verhoeff NP; Wilson AA; Houle S; Remington G; Zipursky RB; Kapur S Am J Psychiatry; 2004 Sep; 161(9):1620-5. PubMed ID: 15337652 [TBL] [Abstract][Full Text] [Related]
10. Treatment of schizophrenia and comorbid substance use disorder. Green AI; Salomon MS; Brenner MJ; Rawlins K Curr Drug Targets CNS Neurol Disord; 2002 Apr; 1(2):129-39. PubMed ID: 12769622 [TBL] [Abstract][Full Text] [Related]
11. Cellular Uptake of the Atypical Antipsychotic Clozapine Is a Carrier-Mediated Process. Dickens D; Rädisch S; Chiduza GN; Giannoudis A; Cross MJ; Malik H; Schaeffeler E; Sison-Young RL; Wilkinson EL; Goldring CE; Schwab M; Pirmohamed M; Nies AT Mol Pharm; 2018 Aug; 15(8):3557-3572. PubMed ID: 29944835 [TBL] [Abstract][Full Text] [Related]
12. Medical management of patients on clozapine: A guide for internists. Lundblad W; Azzam PN; Gopalan P; Ross CA J Hosp Med; 2015 Aug; 10(8):537-43. PubMed ID: 25809850 [TBL] [Abstract][Full Text] [Related]
13. The effects of clozapine versus haloperidol on measures of impulsive aggression and suicidality in chronic schizophrenia patients: an open, nonrandomized, 6-month study. Spivak B; Shabash E; Sheitman B; Weizman A; Mester R J Clin Psychiatry; 2003 Jul; 64(7):755-60. PubMed ID: 12934974 [TBL] [Abstract][Full Text] [Related]
15. The Texas Medication Algorithm Project antipsychotic algorithm for schizophrenia: 2006 update. Moore TA; Buchanan RW; Buckley PF; Chiles JA; Conley RR; Crismon ML; Essock SM; Finnerty M; Marder SR; Miller DD; McEvoy JP; Robinson DG; Schooler NR; Shon SP; Stroup TS; Miller AL J Clin Psychiatry; 2007 Nov; 68(11):1751-62. PubMed ID: 18052569 [TBL] [Abstract][Full Text] [Related]
16. Randomised controlled trials of conventional antipsychotic versus new atypical drugs, and new atypical drugs versus clozapine, in people with schizophrenia responding poorly to, or intolerant of, current drug treatment. Lewis SW; Davies L; Jones PB; Barnes TR; Murray RM; Kerwin R; Taylor D; Hayhurst KP; Markwick A; Lloyd H; Dunn G Health Technol Assess; 2006 May; 10(17):iii-iv, ix-xi, 1-165. PubMed ID: 16707074 [TBL] [Abstract][Full Text] [Related]
17. Treatment of schizophrenia and comorbid substance abuse: pharmacologic approaches. Green AI J Clin Psychiatry; 2006; 67 Suppl 7():31-5; quiz 36-7. PubMed ID: 16961422 [TBL] [Abstract][Full Text] [Related]
18. Clozapine: in prevention of suicide in patients with schizophrenia or schizoaffective disorder. Wagstaff A; Perry C CNS Drugs; 2003; 17(4):273-80; discussion 281-3. PubMed ID: 12665398 [TBL] [Abstract][Full Text] [Related]
19. Clozapine as a Model for Antipsychotic Development. Nucifora FC; Mihaljevic M; Lee BJ; Sawa A Neurotherapeutics; 2017 Jul; 14(3):750-761. PubMed ID: 28653280 [TBL] [Abstract][Full Text] [Related]
20. Suicide and schizophrenia: clozapine and the InterSePT study. International Clozaril/Leponex Suicide Prevention Trial. Meltzer HY J Clin Psychiatry; 1999; 60 Suppl 12():47-50. PubMed ID: 10372612 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]